Home > Insider Trading > Kalvista Pharmaceuticals Inc.

Kalvista Pharmaceuticals Inc. (KALV)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 17

Here is What Hedge Funds Think About KalVista Pharmaceuticals, Inc. (KALV)

We can judge whether KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.

Keep Reading →

December 12th, 2019 - Hedge Funds News

Is KalVista Pharmaceuticals, Inc. (KALV) A Good Stock To Buy?

Is KalVista Pharmaceuticals, Inc.

Keep Reading →

November 6th, 2019 - Hedge Funds News

Hedge Fund and Insider Trading News: Carl Icahn, Ray Dalio, Odey Asset Management, ServisFirst Bancshares, Inc. (SFBS), Kalvista Pharmaceuticals Inc (KALV), and More

(Reuters) - Occidental Petroleum Corp (OXY.N) on Monday sharply criticized activist investor Carl Icahn’s efforts to oust and replace four of its directors, and attacked his slate of board nominees ...

Keep Reading →

July 22nd, 2019 - Hedge Funds Insider Trading

Hedge Funds Have Never Been This Bullish On KalVista Pharmaceuticals, Inc. (KALV)

World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.

Keep Reading →

June 27th, 2019 - Hedge Funds News

Hedge Funds Are Crazy About KalVista Pharmaceuticals, Inc. (KALV)

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...

Keep Reading →

December 23rd, 2018 - Hedge Funds News

13D Filing: RA Capital Management and Kalvista Pharmaceuticals Inc. (KALV)

Joint Filing Agreement by and among the Reporting Persons is incorporated herein by reference to Exhibit 1 to the Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission...

Keep Reading →

November 14th, 2017 - Hedge Funds

13D Filing: Longwood Fund II, L.P. and Kalvista Pharmaceuticals Inc. (KALV)

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

Keep Reading →

October 27th, 2017 - Hedge Funds